Related Experiment Video

Updated: Sep 28, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Obesity in Iranian children

A R Dorosty1, F Siassi, J J Reilly

  • 1Department of Human Nutrition, University of Glasgow, UK.

Archives of Disease in Childhood
|October 23, 2002
PubMed

Insights

Childhood obesity in Iran is higher than expected, with differing prevalence rates based on measurement methods. Consistent monitoring is crucial, but definitions of obesity must be carefully considered.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Childhood obesity is a growing global concern.
  • Accurate prevalence data is essential for effective public health interventions.
  • Different definitions of obesity can lead to varying prevalence estimates.

Purpose of the Study:

  • To determine the prevalence of obesity in Iranian children aged 2-5 years.
  • To compare obesity prevalence using Iranian reference data versus the International Obesity Task Force (IOTF) criteria.
  • To highlight the importance of consistent obesity monitoring in developing countries.

Main Methods:

  • A cross-sectional survey of 4315 children aged 2-5 years in Iran.
  • Body Mass Index (BMI) was calculated and compared against two different reference standards: Iranian data and IOTF criteria.
  • Prevalence rates were analyzed and compared between the two approaches.

Main Results:

  • Obesity prevalence was significantly higher than anticipated in the surveyed population.
  • Obesity rates increased with age.
  • Contradictory trends in prevalence were observed when comparing the Iranian reference data with the IOTF approach.

Conclusions:

  • Monitoring childhood obesity using BMI is vital in developing nations.
  • Discrepancies in obesity definitions can significantly impact prevalence estimates.
  • Careful consideration of obesity definitions is necessary for accurate public health assessments and interventions.

More Related Videos

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil06:48

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil

Published on: July 29, 2020

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...